|
SE0104140D0
(sv)
*
|
2001-12-07 |
2001-12-07 |
Astrazeneca Ab |
Novel Compounds
|
|
ES2354824T3
(es)
*
|
2004-11-04 |
2011-03-18 |
Vertex Pharmaceuticals, Inc. |
Pirazolo[1,5-a]pirimidinas útiles como inhibidores de proteínas cinasas.
|
|
PT1853588E
(pt)
*
|
2005-02-16 |
2008-08-25 |
Astrazeneca Ab |
Compostos químicos
|
|
JP2008540535A
(ja)
*
|
2005-05-12 |
2008-11-20 |
メルク エンド カムパニー インコーポレーテッド |
チロシンキナーゼ阻害剤
|
|
JP2008540622A
(ja)
*
|
2005-05-16 |
2008-11-20 |
アストラゼネカ アクチボラグ |
化合物
|
|
WO2007046867A2
(en)
*
|
2005-05-19 |
2007-04-26 |
Xenon Pharmaceuticals Inc. |
Piperidine derivatives and their uses as therapeutic agents
|
|
KR20080016659A
(ko)
*
|
2005-05-20 |
2008-02-21 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나제의 억제제로서 유용한 피롤로피리딘
|
|
WO2007049041A1
(en)
*
|
2005-10-28 |
2007-05-03 |
Astrazeneca Ab |
4- (3-aminopyrazole) pyrimidine derivatives for use as tyrosine kinase inhibitors in the treatment of cancer
|
|
CN103214484B
(zh)
|
2005-12-13 |
2016-07-06 |
因塞特控股公司 |
作为两面神激酶抑制剂的杂芳基取代的吡咯并[2,3-b]吡啶和吡咯并[2,3-b]嘧啶
|
|
GB0601638D0
(en)
*
|
2006-01-27 |
2006-03-08 |
Merck Sharp & Dohme |
Therapeutic treatment
|
|
US8217177B2
(en)
|
2006-07-14 |
2012-07-10 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
US8198448B2
(en)
|
2006-07-14 |
2012-06-12 |
Amgen Inc. |
Fused heterocyclic derivatives and methods of use
|
|
PE20080403A1
(es)
|
2006-07-14 |
2008-04-25 |
Amgen Inc |
Derivados heterociclicos fusionados y metodos de uso
|
|
ES2403546T3
(es)
*
|
2006-11-03 |
2013-05-20 |
Pharmacyclics, Inc. |
Sonda de actividad de la tirosina-cinasa de Bruton y procedimiento de utilización
|
|
JP5642973B2
(ja)
*
|
2007-03-22 |
2014-12-17 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
Ｊａｋ阻害薬として有用なｎ−複素環式化合物
|
|
WO2008129255A1
(en)
*
|
2007-04-18 |
2008-10-30 |
Astrazeneca Ab |
5-aminopyrazol-3-yl-3h-imidazo [4,5-b] pyridine derivatives and their use for the treatment of cancer
|
|
UA99459C2
(en)
*
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
|
US20100137398A1
(en)
*
|
2007-05-04 |
2010-06-03 |
Novartis Ag |
Use of hdac inhibitors for the treatment of gastrointestinal cancers
|
|
HUE029236T2
(en)
|
2007-06-13 |
2017-02-28 |
Incyte Holdings Corp |
(R) -3- (4- (7H-Pyrrolo [2,3-d] pyrimidin-4-yl) -1H-pyrazol-1-yl) -3-cyclopentylpropanenitrile Crystalline salts of Janus kinase inhibitor
|
|
US8729264B2
(en)
|
2007-09-28 |
2014-05-20 |
Kyowa Hakko Kirin Co., Ltd. |
Agent for prevention and/or treatment of skin diseases
|
|
MX2010005300A
(es)
*
|
2007-11-16 |
2010-06-25 |
Incyte Corp |
4-pirazolil-n-arilpirimidin-2-aminas y 4-pirazolil-n-heteroarilpir imidin-2-aminas como inhibidores de cinasas janus.
|
|
EP2252618A1
(en)
|
2007-12-19 |
2010-11-24 |
Vertex Pharmaceuticals Incorporated |
PYRAZOLO [1,5-a] PYRIMIDINES USEFUL AS JAK2 INHIBITORS
|
|
PE20091268A1
(es)
*
|
2007-12-19 |
2009-09-19 |
Amgen Inc |
Derivados heterociclicos como inhibidores de pi3 quinasa
|
|
EP2265603B1
(en)
|
2008-03-13 |
2014-05-07 |
The General Hospital Corporation |
Inhibitors of the bmp signaling pathway
|
|
UY31885A
(es)
*
|
2008-06-11 |
2010-01-29 |
Astrazeneca Ab |
Derivados de las 1, 3, 5-triazina-2, 4-diaminas-6-sustituidas-n-sustituidas y sales farmacéuticamente aceptables de los mismos, composiciones y aplicaciones.
|
|
EP2376492B1
(en)
*
|
2008-09-19 |
2015-04-08 |
Nerviano Medical Sciences S.r.l. |
3,4 DIHYDRO-2H-PYRROLO[1,2-a]PYRAZIN-1-ONE DERIVATIVES
|
|
RS53350B
(sr)
|
2008-09-22 |
2014-10-31 |
Array Biopharma, Inc. |
Supstituisana jedinjenja imidazo[1,2-b]piridazina kao inhibitori trk kinaze
|
|
RU2011116928A
(ru)
*
|
2008-09-30 |
2012-11-20 |
Астразенека Аб (Se) |
Гетероциклические ингибиторы jак киназы
|
|
CN102271515B
(zh)
*
|
2008-10-31 |
2014-07-02 |
健泰科生物技术公司 |
吡唑并嘧啶jak抑制剂化合物和方法
|
|
GB0821913D0
(en)
|
2008-12-02 |
2009-01-07 |
Price & Co |
Antibacterial compounds
|
|
MY156727A
(en)
*
|
2009-05-22 |
2016-03-15 |
Incyte Corp |
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
EP2432472B1
(en)
|
2009-05-22 |
2019-10-02 |
Incyte Holdings Corporation |
3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
|
|
JP2012528188A
(ja)
*
|
2009-05-28 |
2012-11-12 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ｃ−Ｍｅｔタンパク質キナーゼの阻害剤
|
|
DK2442809T3
(en)
|
2009-06-17 |
2016-12-19 |
Vertex Pharma |
Inhibitors of the replication of influenza virus
|
|
UA110324C2
(en)
|
2009-07-02 |
2015-12-25 |
Genentech Inc |
Jak inhibitory compounds based on pyrazolo pyrimidine
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
TW201113285A
(en)
*
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
CA2771822C
(en)
|
2009-09-04 |
2020-08-11 |
Daniel A. Erlanson |
Bruton's tyrosine kinase inhibitors
|
|
EP3354652B1
(en)
|
2010-03-10 |
2020-05-06 |
Incyte Holdings Corporation |
Piperidin-4-yl azetidine derivatives as jak1 inhibitors
|
|
US20130096160A1
(en)
*
|
2010-04-14 |
2013-04-18 |
Secretary, Department Of Health And Human Services |
Arylthiazolyl piperidines and related compounds as modulators of survival motor neuron (smn) protein production
|
|
EP3450432A1
(en)
|
2010-05-17 |
2019-03-06 |
Incozen Therapeutics Pvt. Ltd. |
Novel 3,5-disubstitued-3h-imidazo[4,5-b]pyridine and 3,5- disubstitued - 3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
|
|
KR102015402B1
(ko)
|
2010-05-20 |
2019-08-28 |
어레이 바이오파마 인크. |
Trk 키나제 저해제로서의 매크로시클릭 화합물
|
|
AR084691A1
(es)
|
2010-05-21 |
2013-06-05 |
Incyte Corp |
Formulacion de uso topico para un inhibidor de jak y metodo para tratar trastorno de la piel
|
|
GB2480814A
(en)
*
|
2010-06-01 |
2011-12-07 |
Summit Corp Plc |
Compounds for the treatment of clostridium difficile-associated disease
|
|
HRP20160397T1
(hr)
|
2010-06-01 |
2016-08-12 |
Summit Therapeutics Plc |
Spojevi za liječenje clostridium difficile povezanih bolesti
|
|
CA2818542A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
WO2012068440A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Heterocyclic-substituted pyrrolopyridines and pyrrolopyrimidines as jak inhibitors
|
|
AU2011343642A1
(en)
*
|
2010-12-16 |
2013-05-02 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
EA031153B1
(ru)
*
|
2011-06-10 |
2018-11-30 |
Мерк Патент Гмбх |
Применение пиримидиновых соединений с btk ингибирующей активностью
|
|
MY165963A
(en)
|
2011-06-20 |
2018-05-18 |
Incyte Holdings Corp |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
|
|
JP2014517079A
(ja)
|
2011-06-22 |
2014-07-17 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
Ａｔｒキナーゼ阻害剤として有用な化合物
|
|
UA118010C2
(uk)
|
2011-08-01 |
2018-11-12 |
Вертекс Фармасьютікалз Інкорпорейтед |
Інгібітори реплікації вірусів грипу
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
US9096605B2
(en)
*
|
2011-08-24 |
2015-08-04 |
Glaxosmithkline Llc |
Pyrazolopyrimidine derivatives as PI3 kinase inhibitors
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
AP3908A
(en)
|
2012-03-30 |
2016-11-24 |
Rhizen Pharmaceuticals Sa |
Novel 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo [4,5-B] pyridine compounds as modulators of C-met protein kinases
|
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲ｊａｋ抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
|
AR091273A1
(es)
|
2012-06-08 |
2015-01-21 |
Biogen Idec Inc |
Inhibidores de pirimidinil tirosina quinasa
|
|
WO2014028829A1
(en)
*
|
2012-08-16 |
2014-02-20 |
The Scripps Research Institute |
Novel kappa opioid ligands
|
|
TWI761825B
(zh)
|
2012-11-15 |
2022-04-21 |
美商英塞特控股公司 |
盧梭利替尼之緩釋性劑型
|
|
WO2014081996A1
(en)
*
|
2012-11-23 |
2014-05-30 |
Glaxosmithkline Llc |
Novel compounds as diacylglycerol acyltransferase inhibitors
|
|
SMT202000713T1
(it)
|
2012-12-07 |
2021-03-15 |
Vertex Pharma |
Pirazolo [1,5-a] pirimidine utili come inibitori dell'atr chinasi per il trattamento di malattie del cancro
|
|
TW201501713A
(zh)
*
|
2013-03-01 |
2015-01-16 |
Kyowa Hakko Kirin Co Ltd |
眼炎症性疾病之預防及／或治療劑
|
|
MX384910B
(es)
|
2013-03-06 |
2025-03-14 |
Incyte Holdings Corp |
Procesos e intermedios para hacer un inhibidor de jak.
|
|
US9682983B2
(en)
|
2013-03-14 |
2017-06-20 |
The Brigham And Women's Hospital, Inc. |
BMP inhibitors and methods of use thereof
|
|
JP2016512815A
(ja)
|
2013-03-15 |
2016-05-09 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
Ａｔｒキナーゼの阻害剤として有用な縮合ピラゾロピリミジン誘導体
|
|
EP2970288A1
(en)
*
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
WO2014143241A1
(en)
|
2013-03-15 |
2014-09-18 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
WO2014175370A1
(ja)
*
|
2013-04-25 |
2014-10-30 |
塩野義製薬株式会社 |
ピロリジン誘導体およびそれらを含有する医薬組成物
|
|
SG11201600815WA
(en)
|
2013-08-07 |
2016-03-30 |
Incyte Corp |
Sustained release dosage forms for a jak1 inhibitor
|
|
RS57541B1
(sr)
|
2013-11-13 |
2018-10-31 |
Vertex Pharma |
Postupci za pripremu inhibitora replikacije virusa gripa
|
|
EP3068776B1
(en)
|
2013-11-13 |
2019-05-29 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of influenza viruses replication
|
|
WO2015073267A1
(en)
*
|
2013-11-15 |
2015-05-21 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
CN104650092B
(zh)
*
|
2013-11-16 |
2017-11-10 |
广东东阳光药业有限公司 |
取代的杂芳基化合物及其组合物和用途
|
|
HUE046727T2
(hu)
|
2013-12-06 |
2020-03-30 |
Vertex Pharma |
Az ATR-kináz inhibitoraként használható vegyület, 2-amino-6-fluoro-N-[5-fluoro-piridin-3-IL]-pirazolo-[1,5-A]-pirimidin-3-karboxamid, ennek elõállítása, különbözõ szilárd formái és ezek radioaktív nyomjelzett származékai
|
|
EA032488B1
(ru)
|
2014-05-23 |
2019-06-28 |
Ф. Хоффманн-Ля Рош Аг |
Соединения 5-хлор-дифторметоксифенилпиразолопиримидина, представляющие собой ингибиторы янус-киназы
|
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
|
CN107074863B
(zh)
|
2014-06-05 |
2019-12-03 |
沃泰克斯药物股份有限公司 |
Atr激酶抑制剂的制备方法及其不同的固体形式
|
|
PL3157566T3
(pl)
|
2014-06-17 |
2019-10-31 |
Vertex Pharma |
Metoda leczenia nowotworu przy użyciu kombinacji inhibitorów chk1 i atr
|
|
WO2016011019A1
(en)
|
2014-07-15 |
2016-01-21 |
The Brigham And Women's Hospital, Inc. |
Compositions and methods for inhibiting bmp
|
|
JP6914834B2
(ja)
|
2014-11-16 |
2021-08-04 |
アレイ バイオファーマ インコーポレイテッド |
（Ｓ）−Ｎ−（５−（（Ｒ）−２−（２，５−ジフルオロフェニル）−ピロリジン−１−イル）−ピラゾロ［１，５−ａ］ピリミジン−３−イル）−３−ヒドロキシピロリジン−１−カルボキサミド硫酸水素塩の結晶形
|
|
JP6704416B2
(ja)
|
2015-05-13 |
2020-06-03 |
バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ |
インフルエンザウイルスの複製の阻害剤を調製する方法
|
|
MA42422A
(fr)
|
2015-05-13 |
2018-05-23 |
Vertex Pharma |
Inhibiteurs de la réplication des virus de la grippe
|
|
KR102678021B1
(ko)
|
2015-09-30 |
2024-06-26 |
버텍스 파마슈티칼스 인코포레이티드 |
Dna 손상제와 병용되는, atr 저해제를 포함하는 암 치료용 약제학적 조성물
|
|
TN2018000138A1
(en)
|
2015-10-26 |
2019-10-04 |
Array Biopharma Inc |
Point mutations in trk inhibitor-resistant cancer and methods relating to the same
|
|
AU2017246554B2
(en)
|
2016-04-04 |
2022-08-18 |
Loxo Oncology, Inc. |
Liquid formulations of (S)-N-(5-((R)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
|
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
|
KR102566858B1
(ko)
|
2016-05-18 |
2023-08-11 |
어레이 바이오파마 인크. |
(s)-n-(5-((r)-2-(2,5-디플루오로페닐)피롤리딘-1-일)-피라졸로[1,5-a]피리미딘-3-일)-3-히드록시피롤리딘-1-카르복사미드의 제조 방법
|
|
IL264173B2
(en)
|
2016-07-18 |
2025-05-01 |
Univ Health Network |
Solid forms of ttk inhibitor
|
|
SG11201900515PA
(en)
|
2016-07-21 |
2019-02-27 |
Biogen Ma Inc |
Succinate forms and compositions of bruton's tyrosine kinase inhibitors
|
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
|
WO2018200855A1
(en)
*
|
2017-04-27 |
2018-11-01 |
The Brigham And Women's Hospital, Inc. |
Novel alk2 inhibitors and methods for inhibiting bmp signaling
|
|
PL233595B1
(pl)
*
|
2017-05-12 |
2019-11-29 |
Celon Pharma Spolka Akcyjna |
Pochodne pirazolo[1,5-a]pirymidyny jako inhibitory kinazy JAK
|
|
WO2018215389A1
(en)
|
2017-05-22 |
2018-11-29 |
F. Hoffmann-La Roche Ag |
Therapeutic compounds and compositions, and methods of use thereof
|
|
US10596161B2
(en)
|
2017-12-08 |
2020-03-24 |
Incyte Corporation |
Low dose combination therapy for treatment of myeloproliferative neoplasms
|
|
EP4616913A3
(en)
*
|
2018-01-29 |
2025-12-10 |
Merck Patent GmbH |
Gcn2 inhibitors and uses thereof
|
|
JP7377207B2
(ja)
|
2018-01-29 |
2023-11-09 |
メルク パテント ゲーエムベーハー |
Ｇｃｎ２阻害剤およびその使用
|
|
JP7393348B2
(ja)
|
2018-01-30 |
2023-12-06 |
インサイト・コーポレイション |
（１－（３－フルオロ－２（トリフルオロメチル）イソニコチニル）ピぺリジン―４－オン）を作製するためのプロセス及び中間体
|
|
CN113768934A
(zh)
|
2018-03-30 |
2021-12-10 |
因赛特公司 |
使用jak抑制剂治疗化脓性汗腺炎
|
|
CA3117695A1
(en)
|
2018-10-26 |
2020-04-30 |
Keros Therapeutics, Inc. |
Crystal forms of an alk2 inhibitor
|
|
AU2019401649B2
(en)
*
|
2018-12-20 |
2025-08-28 |
Incyte Corporation |
Imidazopyridazine and imidazopyridine compounds as inhibitors of activin receptor-like kinase-2
|
|
WO2021222875A1
(en)
|
2020-04-30 |
2021-11-04 |
Keros Therapeutics, Inc. |
Methods of using alk2 inhibitors
|
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
|
WO2022098812A1
(en)
|
2020-11-04 |
2022-05-12 |
Keros Therapeutics, Inc. |
Methods of treating iron overload
|
|
US20250042873A1
(en)
*
|
2021-08-24 |
2025-02-06 |
The Johns Hopkins University |
Compositions and methods for treating proteotoxicity-associated diseases
|
|
CN116987083A
(zh)
*
|
2022-04-25 |
2023-11-03 |
杭州健崃生物科技有限公司 |
吡唑并[1,5-a]嘧啶衍生物及其制备方法和用途
|
|
KR102912267B1
(ko)
|
2023-04-20 |
2026-01-15 |
한국화학연구원 |
신규한 헤테로고리 화합물 또는 이의 약학적으로 허용가능한 염 및 이를 유효성분으로 포함하는 바이러스성 질환의 예방 또는 치료용 약학적 조성물
|